US 8980902
Poly (ADP-ribose) polymerase (PARP) inhibitors
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8980902 (Poly (ADP-ribose) polymerase (PARP) inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P29/00, A61P3/00